Ranibizumab treatment improves the reading speed of patients with neovascular age-related macular degeneration: A nonrandomized clinical trial using the Radner reading chart
Anti-VEGF treatment significantly improved reading ability. Whether BSCVA can serve as a clinically meaningful assessment of reading ability requires further research. Baseline variables may not help to identify patients with poor reading speed responses to treatment.
Authors
- Dóra Reglődi (ORCID: https://orcid.org/0000-0001-5481-5529)
- Christophe Goetz (ORCID: https://orcid.org/0000-0002-8381-2607)
- Jean‐Marc Perone (ORCID: https://orcid.org/0000-0002-1427-7567)
- Adrienne Csutak (ORCID: https://orcid.org/0000-0002-7821-2412)
- George Hayek (ORCID: https://orcid.org/0000-0002-4638-9635)
Institutions
- Mercy Medical Center (US)
- Centre Hospitalier Régional de Metz-Thionville (FR)
- University of Pecs (HU)
Publication Details
- Journal
- Journal Français d Ophtalmologie
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.jfo.2024.104350
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08